Recent Finacing
Recent Raise
Pelican Therapeutics, led by CEO Josiah Hornblower, develops PTX-25, a TNFRSF25 agonist monoclonal antibody to stimulate memory CD8+ T cells and is establishing headquarters and labs in Austin.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor